July 26, 2016 5:51 AM ET

Biotechnology

Company Overview of Promedior, Inc.

Key Executives for Promedior, Inc.

NameBoard RelationshipsTitleAge
Suzanne L. Bruhn Ph.D.24 RelationshipsChief Executive Officer, President and Director53
John A. Getsy DMD, DONo RelationshipsVice President of Clinical Research & Development--
W. Scott Willett Ph.D.No RelationshipsVice President of Biopharmaceutical Development--
Richard Jack Ph.D.No RelationshipsChief Scientific Officer--

Promedior, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Nancy K. Thomason 16 RelationshipsPromedior, Inc.--
Suzanne L. Bruhn Ph.D. 24 RelationshipsPromedior, Inc.53
Darrell Pilling Ph.D. 12 RelationshipsPromedior, Inc.--
Amir H. Nashat Ph.D., Sc.D 133 RelationshipsLiving Proof, Inc.43
Augustine J. Lawlor 131 RelationshipsGITR Inc.60
View All Board Members

Promedior, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
381.0K
Bonus
261.1K
Total Short Term Compensation
476.1K
Total Value of Options
34.2M
Compensation as of Fiscal Year
Promedior, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Cleveland BioLabs, Inc. Announces Executive Changes
July 22, 2016 8:22 PM ET
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas Reed as M. D, Effective July 21, 2016
July 22, 2016 8:18 PM ET
Immunicum AB Appoints Peter Suenaert as Chief Medical Officer
July 22, 2016 10:20 AM ET
ContraFect Corporation Appoints Steven C. Gilman as President and Chief Executive Officer
July 21, 2016 9:32 PM ET
William R. Ringo Intends to Resign from Mirati Therapeutics, Inc.'s Board of Directors
July 21, 2016 8:03 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Promedior, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.